In gastric cancer cells, PCAT-1 induces the resistance of cancer cells into cisplatin therapy by stimulation of ZEB1 through miR-128 inhibition, leading to the enhanced progression and malignancy of gastric cancer cells [221]. The gene discussed is PCAT1; the disease is cancer.